Craig E.  Hunsaker net worth and biography

Craig Hunsaker Biography and Net Worth

EVP of Alphatec
Craig Hunsaker has served as Executive Vice President, People & Culture since September 2016, and as General Counsel since March 2017.  In these roles, he is responsible for all aspects of employee recruitment, development, engagement and corporate culture, and is the Company’s chief legal officer and Corporate Secretary. Craig's professional career includes 16 years practicing law at some of the world's largest technology focused law firms, advising and defending companies and management with respect to their people and trade secrets decisions, while holding various leadership positions. Craig left full-time legal practice in 2009, when he joined NuVasive, Inc., a publicly traded spinal implant company, first to serve as Vice President, Legal Affairs, then as Senior Vice President, Global Human Resources until March 2014.  From April 2014 until he joined Alphatec Spine, Craig owned a consulting business, assisting employers in the areas of Employment Law and Human Resources, including as Senior Advisor, Human Resources at General Atomics, a San Diego-based defense contractor. Craig received his J.D. from Columbia University School of Law, where he was a Harlan Fiske Stone Scholar, and his B.S. in International Business & Finance from Brigham Young University.

What is Craig E. Hunsaker's net worth?

The estimated net worth of Craig E. Hunsaker is at least $27.43 million as of October 31st, 2025. Mr. Hunsaker owns 1,289,142 shares of Alphatec stock worth more than $27,432,942 as of December 4th. This net worth approximation does not reflect any other assets that Mr. Hunsaker may own. Additionally, Mr. Hunsaker receives a salary of $909,330.00 as EVP at Alphatec. Learn More about Craig E. Hunsaker's net worth.

How old is Craig E. Hunsaker?

Mr. Hunsaker is currently 60 years old. There are 6 older executives and no younger executives at Alphatec. The oldest executive at Alphatec is Mr. Jonathan Allen, Executive Vice President of Commercial Operations, who is 64 years old. Learn More on Craig E. Hunsaker's age.

What is Craig E. Hunsaker's salary?

As the EVP of Alphatec Holdings, Inc., Mr. Hunsaker earns $909,330.00 per year. The highest earning executive at Alphatec is Mr. Patrick S. Miles, Executive Chairman, CEO & President, who commands a salary of $1,590,000.00 per year. Learn More on Craig E. Hunsaker's salary.

How do I contact Craig E. Hunsaker?

The corporate mailing address for Mr. Hunsaker and other Alphatec executives is 5818 EL CAMINO REAL, CARLSBAD CA, 92008. Alphatec can also be reached via phone at (760) 431-9286 and via email at [email protected]. Learn More on Craig E. Hunsaker's contact information.

Has Craig E. Hunsaker been buying or selling shares of Alphatec?

Over the course of the past ninety days, Craig E. Hunsaker has sold $1,995,000.00 in Alphatec stock. Most recently, Craig E. Hunsaker sold 100,000 shares of the business's stock in a transaction on Friday, October 31st. The shares were sold at an average price of $19.95, for a transaction totalling $1,995,000.00. Following the completion of the sale, the executive vice president now directly owns 1,289,142 shares of the company's stock, valued at $25,718,382.90. Learn More on Craig E. Hunsaker's trading history.

Who are Alphatec's active insiders?

Alphatec's insider roster includes Evan Bakst (Director), Jeffrey Black (CFO), David Demski (Director), Jason Hochberg (Director), Craig Hunsaker (EVP), Mortimer III (Director), John Koning (Chief Financial Officer), Scott Lish (SVP), Tyson Marshall (General Counsel & Corporate Secretary), Patrick Miles (CEO), David Mowry (Director), David Pelizzon (Director), Jennifer Pritzker (Major Shareholder), Jeffrey Rydin (Director), Paul Segal (Major Shareholder), David Sponsel (EVP), and James Tullis (Director). Learn More on Alphatec's active insiders.

Are insiders buying or selling shares of Alphatec?

In the last twelve months, insiders at the medical technology company sold shares 47 times. They sold a total of 3,582,443 shares worth more than $63,320,843.20. The most recent insider tranaction occured on December, 1st when CEO Patrick Miles sold 100,000 shares worth more than $2,211,000.00. Insiders at Alphatec own 20.9% of the company. Learn More about insider trades at Alphatec.

Information on this page was last updated on 12/1/2025.

Craig E. Hunsaker Insider Trading History at Alphatec

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/31/2025Sell100,000$19.95$1,995,000.001,289,142View SEC Filing Icon  
8/6/2025Sell10,876$15.33$166,729.081,389,142View SEC Filing Icon  
8/5/2025Sell50,000$15.00$750,000.001,400,018View SEC Filing Icon  
6/5/2025Sell13,878$12.36$171,532.081,450,018View SEC Filing Icon  
6/4/2025Sell186,122$12.34$2,296,745.481,463,896View SEC Filing Icon  
2/26/2024Sell41,560$15.05$625,478.001,188,444View SEC Filing Icon  
6/27/2023Sell6,542$18.00$117,756.001,220,914View SEC Filing Icon  
5/15/2023Sell58,238$15.29$890,459.021,227,456View SEC Filing Icon  
4/24/2023Sell28,311$15.85$448,729.351,285,694View SEC Filing Icon  
3/1/2023Sell80,023$16.00$1,280,368.001,346,828View SEC Filing Icon  
2/27/2023Sell36,072$14.74$531,701.281,436,789View SEC Filing Icon  
2/21/2023Sell65,716$14.04$922,652.641,472,861View SEC Filing Icon  
2/9/2023Sell60,000$14.00$840,000.001,435,995View SEC Filing Icon  
8/17/2022Sell9,895$9.07$89,747.651,251,174View SEC Filing Icon  
8/15/2022Sell30,000$9.70$291,000.001,261,969View SEC Filing Icon  
6/13/2022Sell30,000$7.31$219,300.001,331,729View SEC Filing Icon  
6/1/2022Sell70,000$7.16$501,200.001,362,229View SEC Filing Icon  
11/12/2021Buy15,000$11.66$174,900.00View SEC Filing Icon  
4/8/2021Sell25,000$16.23$405,750.001,008,361View SEC Filing Icon  
10/8/2020Sell62,731$8.62$540,741.221,016,092View SEC Filing Icon  
1/15/2020Sell32,000$7.75$248,000.00794,948View SEC Filing Icon  
11/18/2019Sell32,000$7.25$232,000.00797,448View SEC Filing Icon  
11/4/2019Sell12,000$7.00$84,000.00844,768View SEC Filing Icon  
10/31/2019Sell32,000$6.75$216,000.00844,768View SEC Filing Icon  
8/12/2019Sell100,000$5.88$588,000.00811,112View SEC Filing Icon  
8/8/2019Sell50,000$5.75$287,500.00811,112View SEC Filing Icon  
7/25/2019Sell50,000$5.00$250,000.00811,112View SEC Filing Icon  
5/15/2019Sell50,000$4.50$225,000.00View SEC Filing Icon  
4/30/2019Sell50,000$4.00$200,000.00626,014View SEC Filing Icon  
See Full Table

Craig E. Hunsaker Buying and Selling Activity at Alphatec

This chart shows Craig E Hunsaker's buying and selling at Alphatec by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Alphatec Company Overview

Alphatec logo
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.
Read More

Today's Range

Now: $21.28
Low: $21.14
High: $21.57

50 Day Range

MA: $17.66
Low: $13.14
High: $23.23

2 Week Range

Now: $21.28
Low: $8.69
High: $22.66

Volume

1,282,338 shs

Average Volume

2,121,082 shs

Market Capitalization

$3.16 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.08